As of May, 2019 China and the Unites States have been in a trade war for more than a year with historical level of goods facing surging tariff barriers. The trade war, even if settled eventually, has already deeply affected China's approach to globalization. In this seminar, Dr. Chen will share his ideas on why the trade disputes between China and the U.S. could be a persistent phenomenon and what is China doing and will do to in its economic reforms under a more unfriendly U.S. era.

Dr. Bo Chen
Professor Bo Chen received his Ph.D. degree in Economics from Simon Fraser University (Vancouver, Canada) in 2008. Dr. Chen is the Chutian Professor of Economics and the executive director of Institute of Free Trade Zone (FTZ) of Huazhong University of Science and Technology. He is also a research associate of the Federal Reserve Bank of Dallas.

Since June 2013, Dr. Chen has participated in the consultation for the Shanghai, Guangdong, and Hubei Pilot Free Trade Zones (FTZs). He was invited to give talks to senior officers at the Ministry of Treasury and the Ministry of Commerce of China. Furthermore, he is a senior lecturer to the executives of Stateowned Enterprises (SOEs) by the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council on issues such as the GHM Great Bay Area Development, Belt & Road Initiative and SOE Reforms.

Recently he has been frequently consulted by Chinese government for the ongoing trade war between China and the United States. His advice has been selected to report to the Standing Committee of the Political Bureau. His opinions appear in various mainstream media such as CCTV, Xinhua Media, Lianhe Zaobao, BBC, The Economist, and the Wall Street Journal. Besides the central/federal governments of China, U.S.A. and Australia, Dr. Chen has also given keynote speeches on China Macroeconomic Policies and Reforms to many leading business groups and think tanks such as the Goldman Sachs Group, HSBC, the Deutsche Bank, BAML, Citi Bank, BMW, the Asian Society, the Rhodium Group, and CEPII.